The U.S. Department of Justice says the chief executive and medical director of Fast Lab Technologies allegedly engaged in a $500 million fraud scheme involving COVID-19 tests.
Adrianne Appel
Adrianne Appel writes regulatory news, policy, and trends for Compliance Week. She previously reported about policy developments for Bloomberg Law and Bloomberg Government.
Email: adrianne.appel@complianceweek.com
LinkedIn: Follow
Posted inRegulatory Enforcement
OFAC cracks down on Iran’s oil trade with new sanctions sweep
More than 50 people and 50 ships connected to a top Iranian official were added to the U.S. Treasury’s sanctions list on Wednesday, according to the Office of Foreign Assets Control.
Posted inData Privacy
Kentucky files suit against Temu alleging it stole state intellectual property and violated privacy
Kentucky took aim at Chinese company Temu, alleging in a lawsuit that it counterfeited popular Kentucky-designed merchandise and violated customers’ privacy.
Posted inRegulatory Policy
EPA follows through on Trump threat and proposes killing air pollution rule
The U.S. Environmental Protection Agency has placed a decades-old rule that limits air pollution from cars and trucks on the chopping block, potentially endangering the Clean Air Act.
Posted inRegulatory Enforcement
Florida telecomm agrees to pay more than $128 million for alleged false claims
A Florida wireless company and its chief executive officer will pay more than $128 million to settle civil and criminal allegations that they defrauded a federal low-income telecommunications program, according to the Department of Justice.
Posted inRegulatory Policy
PCAOB faces uncertain future as SEC Chair solicits new candidates
SEC Chair Paul Atkins is soliciting candidates for all five seats on the Public Company Accounting Oversight Board, he announced Wednesday.
Posted inRegulatory Enforcement
3M tops U.S. corporate penalties list with $18.7B in fines over four years, survey says
The 3M Company paid more than $18.7 billion in penalties over four years, more than any other major U.S. company tracked in a new survey.
Posted inRegulatory Enforcement
CVS hit with nearly $1 billion fine in Omnicare false claims verdict
CVS has vowed to appeal $948.8 million in fines and damages imposed by a judge Tuesday on its Omnicare unit, for billing Medicare for tens of thousands of false claims.
Posted inRegulatory Enforcement
DOJ wants less monitoring, more self disclosure with fine reductions, Galeotti says
The Criminal Division of the Department of Justice, continuing its aggressive, pro-business stance, has revamped key, white-collar crime enforcement policies, including clarifying fine reductions in its self-disclosure program and curbing its use of monitorships.
Posted inRegulatory Enforcement
DOJ charges crypto executive with laundering $530M for sanctioned Russian banks
The Department of Justice has charged the founder of cryptocurrency company Evita with 22 violations for allegedly laundering more than $500 million through U.S. banks and cryptocurrency exchanges, on behalf of sanctioned Russian entities.
